26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Bhuvaneswar C, Colon J, Matthews J, Burke B, Stern TA. Psychiatric care of deaf patients in the general hospital: an overview. Psychosomatics. 56: 1-11. PMID 25619669 DOI: 10.1016/j.psym.2014.06.001  0.96
2015 Matthews JD, Doorley J. Cognitive behavioral therapies for chronic depression The Massachusetts General Hospital Handbook of Cognitive Behavioral Therapy. 301-317. DOI: 10.1007/978-1-4939-2605-3_22  0.96
2013 Matthews JD, Siefert CJ, Blais MA, Park LT, Siefert CJ, Welch CA, Dubois CM, van Nieuwenhuizen AO, Rooney KO, Seabrook RC, Durham LE, Adams HC, Fava M. A double-blind, placebo-controlled study of the impact of galantamine on anterograde memory impairment during electroconvulsive therapy. The Journal of Ect. 29: 170-8. PMID 23519225 DOI: 10.1097/YCT.0b013e31828b3523  0.96
2010 Dording CM, Mischoulon D, Goodness TM, Baer L, Clain A, Stewart JW, Matthews JD, McGrath PJ, Nierenberg AA, Fava M, Papakostas GI. Psychoticism and paranoid ideation in patients with nonpsychotic major depressive disorder: prevalence, response to treatment, and impact on short- and long-term treatment outcome. Cns Spectrums. 15: 515-21. PMID 20703198 DOI: 10.1017/S1092852900000468  0.96
2010 Farabaugh A, Locascio JJ, Yap L, Growdon J, Fava M, Crawford C, Matthews J, McCutchen J, Buchin J, Pava J, Alpert JE. Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics. 51: 124-9. PMID 20332287 DOI: 10.1176/appi.psy.51.2.124  0.96
2010 Petersen TJ, Pava JA, Buchin J, Matthews JD, Papakostas GI, Nierenberg AA, Holmes AJ, Bogdan R, Graves LM, Harley RM, Fava M. The role of cognitive-behavioral therapy and fluoxetine in prevention of recurrence of major depressive disorder Cognitive Therapy and Research. 34: 13-23. DOI: 10.1007/s10608-007-9166-6  0.96
2009 Dording CM, Sinicropi-Yao L, Papakostas G, Matthews JD, Nierenberg AA, Fava M, Mischoulon D. The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder. Nordic Journal of Psychiatry. 63: 420-5. PMID 19521922 DOI: 10.1080/08039480903015396  0.96
2009 Matthews JD, Siefert C, Dording C, Denninger JW, Park L, van Nieuwenhuizen AO, Sklarsky K, Hilliker S, Homberger C, Rooney K, Fava M. An open study of aripiprazole and escitalopram for psychotic major depressive disorder. Journal of Clinical Psychopharmacology. 29: 73-6. PMID 19142112 DOI: 10.1097/JCP.0b013e318193dfb4  0.96
2008 Matthews JD, Blais M, Park L, Welch C, Baity M, Murakami J, Sklarsky K, Homberger C, Fava M. The impact of galantamine on cognition and mood during electroconvulsive therapy: a pilot study. Journal of Psychiatric Research. 42: 526-31. PMID 17681545 DOI: 10.1016/J.Jpsychires.2007.06.002  0.96
2007 Park LT, Matthews JD, Maytal G, Stern TA. Evaluation and treatment of poor sleep. Primary Care Companion to the Journal of Clinical Psychiatry. 9: 224-9. PMID 17632655  0.96
2003 Blais MA, Matthews J, Lipkis-Orlando R, Lechner E, Jacobo M, Lincoln R, Gulliver C, Herman JB, Goodman AF. Predicting length of stay on an acute care medical psychiatric inpatient service Administration and Policy in Mental Health. 31: 15-29. PMID 14650646 DOI: 10.1023/A:1026044106172  0.96
2002 Blais MA, Matthews J, Lipkis-Orlando R, O'Keefe SM, Jacobo M, Rivas-Vazquez RA, Summergrad P. Development and application of a brief multi-faceted tool for evaluating inpatient psychiatric care Administration and Policy in Mental Health. 30: 159-172. PMID 12680619 DOI: 10.1023/A:1022537218940  0.96
2002 Matthews JD, Bottonari KA, Polania LM, Mischoulon D, Dording CM, Irvin R, Fava M. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses. The Journal of Clinical Psychiatry. 63: 1164-70. PMID 12523877 DOI: 10.4088/Jcp.V63N1212  0.96
2002 Sonawalla SB, Farabaugh AH, Leslie VM, Pava JA, Matthews JD, Fava M. Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 26: 1415-9. PMID 12502032 DOI: 10.1016/S0278-5846(02)00268-3  0.96
2002 Perlis RH, Nierenberg AA, Alpert JE, Pava J, Matthews JD, Buchin J, Sickinger AH, Fava M. Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder. Journal of Clinical Psychopharmacology. 22: 474-80. PMID 12352270 DOI: 10.1097/00004714-200210000-00006  0.96
2002 Sonawalla SB, Farabaugh AH, Leslie VM, Pava JA, Matthews JD, Fava M. Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 26: 415-9. PMID 11999889 DOI: 10.1016/S0278-5846(01)00265-2  0.96
2002 Farabaugh A, Mischoulon D, Yeung A, Alpert J, Matthews J, Pava J, Fava M. Predictors of stable personality disorder diagnoses in outpatients with remitted depression Journal of Nervous and Mental Disease. 190: 248-256. PMID 11960086 DOI: 10.1097/00005053-200204000-00006  0.96
2001 Gagliardi A, Chung RT, Matthews J, Querques J. A 52 year-old man with depression, heroin dependence, and hepatitis C-related cirrhosis: A medical-psychiatric Gordian Knot Medicine and Psychiatry. 4: 2-5.  0.96
2000 Matthews JD, Fava M. Risk of suicidality in depression with serotonergic antidepressants. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 12: 43-50. PMID 10798825 DOI: 10.1023/A:1009027010991  0.96
1999 Nierenberg AA, Burt T, Matthews J, Weiss AP. Mania associated with St. John's wort Biological Psychiatry. 46: 1707-1708. PMID 10624554 DOI: 10.1016/S0006-3223(99)00233-4  0.96
1998 Blais MA, Matthews J, Schouten R, O'Keefe SM, Summergrad P. Stability and predictive value of self-report personality traits pre- and post-electroconvulsive therapy: A preliminary study Comprehensive Psychiatry. 39: 231-235. PMID 9675509 DOI: 10.1016/S0010-440X(98)90066-9  0.96
1998 Pollack MH, Matthews J, Scott EL. Gabapentin as a potential treatment for anxiety disorders. The American Journal of Psychiatry. 155: 992-3. PMID 9659873  0.96
1997 Zaretsky AE, Fava M, Davidson KG, Pava JA, Matthews J, Rosenbaum JF. Are dependency and self-criticism risk factors for major depressive disorder? Canadian Journal of Psychiatry. 42: 291-297. PMID 9114945 DOI: 10.1177/070674379704200307  0.96
1997 Fava M, Abraham M, Clancy-Colecchi K, Pava JA, Matthews J, Rosenbaum JF. Eating disorder symptomatology in major depression Journal of Nervous and Mental Disease. 185: 140-144. PMID 9091594 DOI: 10.1097/00005053-199703000-00002  0.96
1992 Gardos G, Cole JO, Matthews JD, Nierenberg AA, Dugan SJ. The acute effects of a loading dose of phenylalanine in unipolar depressed patients with and without tardive dyskinesia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 6: 241-7. PMID 1352977  0.96
1992 Gardos G, Teicher MH, Lipinski JF, Matthews JD, Morrison L, Conley C, Cole JO. Quantitative assessment of psychomotor activity in patients with neuroleptic-induced akathisia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 16: 27-37. PMID 1348369 DOI: 10.1016/0278-5846(92)90005-Y  0.96
Show low-probability matches.